The box containing the modern COVID-19 vaccine is set to be shipped to the McKesson distribution center on December 20, 2020, in Olive Branch, Mississippi, US.
Paul Sankhya | Reuters
A member of presidential election Joe Biden Kovid-19 advisory committee said Thursday that the Biden administration’s plan to release nearly every available dose of Pfizer and Modern’s coronavirus vaccine to states should not become a supply issue.
The advisory team has held several conversations with vaccine manufacturers Pfizer, Moderna and Johnson & Johnson regarding supply issues, Drs. Said Celine Gounder, who sits on the panel and is an infectious disease specialist at the NY Grossman School of Medicine.
The Biden administration is “convinced”, except for some unexpected “manufacturing snafu”, that people will have no problem getting their second shots on time, she said.
“It’s not something we’re so worried about,” Gounder told the Johns Hopkins Bloomberg School of Public Health during a webcast Thursday afternoon. “If you look at the timeline for production, they’re actually going to release more and more doses over time, so that can really open things up significantly.”
Shortly before the gounder’s remarks, Biden hopes to unveil his plan to vaccinate the US population and end the epidemic that killed at least 385,503 Americans in about a year. Biden criticized the Trump administration’s vaccine rollout strategy, saying that at the current pace “it would take months to vaccinate the American people, not months.”
The pace of vaccination in America is much slower than the authorities. According to data compiled by the Centers for Disease Control and Prevention, as of 9 a.m. Wednesday, more than 29.3 million doses of the vaccine were distributed across the US, but just over 10.2 million shots have been administered. The number is crying out to the target of 20 million Americans being immunized by the federal government by the end of 2020 and 50 million by the end of this month.
Some state governors, including Andrew Cuomo of the New York government, have complained about vaccine availability, saying that the lack of doses has hindered their ability to vaccinate people.
The Trump administration on Tuesday adopted Biden’s plan most of which he held for second-round shots of Pfizer and Modern’s two-dose vaccines to withdraw.
General Gustave Perna, who oversees logistics for President Donald Trump’s vaccine program, Operation Warp Speed, previously said setting aside doses of Kovid was “good Army General Officer planning” to ensure that So that the right people can get shots when needed.
In an effort to speed up the pace of vaccination, the Trump administration also changed the way vaccine doses are allocated to states, and the CDC expanded vaccine eligibility for everyone 65 and older, as well as comical conditions such as diabetes and heart Done with Disease.
Some public health experts have questioned whether companies can manufacture higher doses before people need their second shots.
The gounder said Thursday that the administration is still planning to keep “a small buffer” of the dose in the reserve.
“We’re going to release almost everyone [doses] With a small buffer left because we want to speed up the pace at which vaccination is taking place, “she said.” It is really a decision how to manage supply. It is not a recommendation regarding vaccination or schedule supplements. “